Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Stanley Lapidus currently holds 337,392 shares of Lucid Diagnostics Inc. (LUCD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stanley Lapidus has been a net seller of LUCD stock. They have purchased $0 and sold $210.7K worth of shares.
Stanley Lapidus's most recent insider trade was on Feb 20, 2026, when they sold 123,000 shares at $0.00 per share.
Stanley Lapidus serves as Executive at Lucid Diagnostics Inc. (LUCD). They have executed 21 insider transactions totaling $210.7K over their tenure at the company.
Stanley Lapidus holds the position of Executive at Lucid Diagnostics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Stanley Lapidus has shown a selling trading pattern, with $0 in total purchases and $210.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Stanley Lapidus was on Jun 5, 2018, when they sold $53.2K worth of TTOO shares. This transaction involved 6,000 shares at $8.87 per share.
Stanley Lapidus currently owns 337,392 shares of Lucid Diagnostics Inc. (LUCD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Stanley Lapidus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Stanley Lapidus has 21 Form 4 filings on record as an insider at Lucid Diagnostics Inc..
Set alerts for Stanley Lapidus and 40,000+ other insiders.